6085. Pabacaine. (F.D.C. No. 44147. S. No. 6^-712 P.) QUANTITY : 1,550 ampuls at Los Angeles, Calif., in possession of Brown Pharr maceutieal Co. SHIPPED : 10-19-59, from Philadelphia, Pa., by the Philadelphia Ampule Lab oratories, Inc. LABEL IN PAET: (Ampul) "5 cc Ampule Pabacaine each ampule contains: Pabacaine 100 mg. Ascorbic Acid 50 mg. * * * Glutamic Acid 50 mg * * * Exclusive U.S. Distributors-The Brown Pharmaceutical Co., Los Angeles, Calif. 9966." ACCOMPANYING LABELING : Brochures entitled "Research On The Use of H3 In The Treatment Of Old Age And Other Diseases." RESULTS OP INVESTIGATION : The brochures were printed locally for the dealer. LIBELED: 12-31-59, S. Dist. Calif. CHARGE: 502(a)-while held for sale, the labeling which accompanied the article contained statements that the article appeared to make old people younger than their natural age; usually they experienced a marked improve- ment in general health; some elderly patients found their new hair growth was youthfully dark in color; in certain kinds of baldness, hair growth was restored dramatically; often the patients showed a marked improvement in their skin texture; a large percentage became strong enough to resume work again; many people crippled with arthritis had been strikingly helped; heart action and blood circulation were usually much improved; treatment had cured many cases of stomach ulcers; profound effects were shown in the central nervous system, with some men and women achieving greater improve- ment in eyesight and hearing; the brain functions frequently improved, with most elderly patients exhibiting notable strengthening of memory and atten- tion ; and treatment was also given to younger men and women suffering from arthritis, neuralgia, stomach ulcers, premature baldness, and other ailments; which statements were false and misleading since the article was not capable of fulfilling the promises of benefit stated and implied; 505(a)-the article was a new drug within the meaning of the law, since its safety for use in the treatment of old age and other conditions mentioned in its accompanying labeling had not been established and an application filed pursuant to the law was not effective with respect to such drug. DISPOSITION : 1-26-60. Default-destruction.